window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : August 18, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

pharmaceutical excipients

  • Drug Delivery & Formulation

    Lubrizol excipient recognised at CPhI China Pharma Excipients Awards

    Lubrizol’s Apisolex polymer has received a Silver award at the [...]

    June 19, 2026
  • Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    BIOGRUND and Seprify launch plant-based tablet coating to replace titanium dioxide

    BIOGRUND and Seprify have introduced a plant-based tablet coating system [...]

    May 5, 2026
  • Drug Delivery & Formulation,Drug Discovery & Development,Manufacturing & Supply Chain

    DFE Pharma launches continuous manufacturing platform with Gericke to support formulation development

    DFE Pharma has launched a new continuous manufacturing platform in [...]

    May 5, 2026
  • Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    DFE Pharma launches EcoLact 2030 to cut CO₂ emissions across lactose excipients

    DFE Pharma has launched EcoLact 2030, a sustainability programme covering [...]

    May 5, 2026
  • Manufacturing & Supply Chain

    Video: ADM outlines glycerin excipient focus at CPHI Frankfurt

    May 5, 2026
  • Drug Discovery & Development

    Lubrizol hits clinical milestone with novel solubility-enhancing excipient

    Apisolex polymer excipient formulation enters Phase 1 trials, supporting delivery [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain

    Colorcon and ASHA Cellulose partner to advance barrier membrane technologies for pharma and nutra formulations

    Colorcon, a specialist in film coatings, excipients, and controlled release [...]

    May 5, 2026
  • Clinical & Regulatory

    DFE Pharma secures ISO 22301 certification to safeguard excipients supply

    DFE Pharma has achieved ISO 22301 certification for Business Continuity [...]

    May 5, 2026
  • Biotech & Pharma Business

    Roquette unveils new organisational structure following IFF Pharma Solutions acquisition

    Company creates two business groups to drive growth across health, [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Delivery & Formulation

    Roquette completes IFF Pharma Solutions acquisition, strengthening position in global excipients market

    Roquette has announced the successful completion of its acquisition of [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • CN Bio wins Innovate UK grant to develop human-relevant drug testing workflow
    Categories: Digital & Data, Drug Discovery & Development, Manufacturing & Supply Chain, Research & Development
  • FDA grants Priority Review to Belite Bio’s tinlarebant for Stargardt disease
    Categories: Clinical & Regulatory, Drug Delivery & Formulation, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Skylark Bio doses first patient in Phase 1/2 trial for GJB2-related deafness
    Categories: Advanced Therapies, Clinical & Regulatory, Genomics and sequencing, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top